Labcorp EBIT 2010-2024 | LH

Labcorp EBIT for the quarter ending December 31, 2024 was $0.217B, a 276.3% decline year-over-year.

  • Labcorp 2024 EBIT was 1.087B, a 49.77% increase from 2023.
  • Labcorp 2023 EBIT was 0.726B, a 49.49% decline from 2022.
  • Labcorp 2022 EBIT was 1.437B, a 52.88% decline from 2021.

EBIT can be defined as earnings before interest and taxes.

Labcorp EBIT 2010-2024 | LH

  • Labcorp 2024 EBIT was 1.087B, a 49.77% increase from 2023.
  • Labcorp 2023 EBIT was 0.726B, a 49.49% decline from 2022.
  • Labcorp 2022 EBIT was 1.437B, a 52.88% decline from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$75.6B
Becton Dickinson (BDX)$65.4B
Cardinal Health (CAH)$30.8B
Straumann Holding AG (SAUHY)$23.4B
Cooper (COO)$17.7B
Align Technology (ALGN)$14.8B
West Pharmaceutical Services (WST)$14.7B
Henry Schein (HSIC)$9.7B
Merit Medical Systems (MMSI)$6.2B
DENTSPLY SIRONA (XRAY)$3.8B
Patterson (PDCO)$2.7B
CONMED (CNMD)$1.9B
STAAR Surgical (STAA)$830M
Lifevantage (LFVN)$211M
Pro-Dex (PDEX)$109M